Search
Close this search box.

Production and Engineering of Market-Ready Lysozymes for Food Animals

Facebook
Twitter
Email
LinkedIn

Generating solutions

Status

Active

Competition

Genomic Applications Partnership Program

Genome Centre(s)

GE3LS

No

Project Leader(s)

Fiscal Year Project Launched

2022-2023

Project Description

The use of antibiotics in food animal production improves growth performance and prevents disease proliferation. Studies have linked antibiotic usage in food animals to antibiotic resistance of bacteria. Antibiotic-resistant bacteria can be transmitted to humans through the food chain, posing a threat to human health. Lysozymes are part of the innate immune system of animals and can have equivalent performance to antibiotics. This project will use genomics-derived technology to economically produce lysozyme formulations that will be used to improve gut health and productivity in food animals. The use of lysozymes in animal feed will improve feed conversion and is expected to save Canadian livestock producers over $300 million in feed costs. It will also reduce antibiotic usage in food animals that could lower the emergence of antibiotic-resistance bacteria and therefore lower the risk of transmission to humans.

Facebook
Twitter
Email
LinkedIn